Related Experiment Videos
Evidence for a suppressor cell system in human kidney allograft tolerance
Transplantation Proceedings
|March 1, 1981
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Articulating the value of health research.
QJM : monthly journal of the Association of Physicians·2014
Identification of new microRNAs targeting genes regulating the Pi/PPi balance in chondrocytes.
Bio-medical materials and engineering·2014
Long-term exposure to belatacept in recipients of extended criteria donor kidneys.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Successful Heart and Renal Allograft Transplantation From Patients With Child-Pugh Class C Cirrhosis.
Transplantation proceedings·2026
Empagliflozin Alleviates Renal Ischemia-Reperfusion Injury by Targeting AMPK/NLRP3 Signaling.
Transplantation proceedings·2026
Risk-Stratified 2 mg/kg ATG Induction in Kidney Transplantation: Comparing Two- and Three-Dose Regimens at a Single Center.
Transplantation proceedings·2026
Hypothermic Machine Perfusion Modifies the Impact of Cold Ischemia Time on Kidney Transplant Outcomes: A Single-Center Analysis.
Transplantation proceedings·2026
Feasibility of 8 Gy TBI-Busulfan-Fludarabine Conditioning with Post-Transplant Cyclophosphamide for Pediatric High-Risk or Relapsed Acute Lymphoblastic Leukemia.
Transplantation and cellular therapy·2026